N/A

N/A

Published by: Quantifize
Downloads
Revenue

Description

SCAI has teamed up with the BMC2 Registry to create the SCAI PCI Risk Calculator will allow users to use one common tool to make a pre-procedure assessment of post-PCI risks including:
1)Mortality
2)Acute kidney injury
3)Transfusion
Not only can risks be calculated pre-procedure, but you only need to input patient date one calculator to receive these three scores.
The SCAI PCI Risk Calculator was developed with the generous support of The Medicines Company.
SCAI gratefully acknowledges this support, while taking sole responsibility for all content developed and disseminated through this effort.
Hide Show More...

Screenshots

N/A FAQ

  • Is SCAI PCI Risk Calculator free?

    Yes, SCAI PCI Risk Calculator is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is SCAI PCI Risk Calculator legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does SCAI PCI Risk Calculator cost?

    SCAI PCI Risk Calculator is free.

  • What is SCAI PCI Risk Calculator revenue?

    To get estimated revenue of SCAI PCI Risk Calculator app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Taiwan yet.
Ratings History

N/A Reviews

No Reviews in Taiwan
App doesn't have any reviews in Taiwan yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Keywords

SCAI PCI Risk Calculator Installs

Last 30 days

SCAI PCI Risk Calculator Revenue

Last 30 days

N/A Revenue and Downloads

Gain valuable insights into SCAI PCI Risk Calculator performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Publisher
Quantifize
Languages
German
Recent release
1.0.3 (9 years ago )
Released on
May 21, 2014 (10 years ago )
Last Updated
3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.